GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Trinity Biotech PLC (NAS:TRIB) » Definitions » Net Intangibles Purchase And Sale

Trinity Biotech (Trinity Biotech) Net Intangibles Purchase And Sale : $-1.92 Mil (TTM As of Sep. 2023)


View and export this data going back to 1995. Start your Free Trial

What is Trinity Biotech Net Intangibles Purchase And Sale?

Net Intangibles purchase and sale means the net cash inflow received by a company that comes from the purchase and sale of intangibles. It equals the cash received from sale of intangibles minus the cash spent on purchasing intangibles.

Trinity Biotech's net Intangibles purchase and sale for the three months ended in Sep. 2023 was $-0.49 Mil. Its net Intangibles purchase and sale for the trailing twelve months (TTM) ended in Sep. 2023 was $-1.92 Mil.

Trinity Biotech Net Intangibles Purchase And Sale Historical Data

The historical data trend for Trinity Biotech's Net Intangibles Purchase And Sale can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Trinity Biotech Net Intangibles Purchase And Sale Chart

Trinity Biotech Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Net Intangibles Purchase And Sale
Get a 7-Day Free Trial Premium Member Only Premium Member Only -9.86 -9.72 -6.99 -6.88 -4.88

Trinity Biotech Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
Net Intangibles Purchase And Sale Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1.00 -0.66 -0.36 -0.41 -0.49

Trinity Biotech Net Intangibles Purchase And Sale Calculation

Net Intangibles purchase and sale means the net cash inflow received by a company that comes from the purchase and sale of intangibles. It equals the cash received from sale of intangibles minus the cash spent on purchasing intangibles.

Net Intangibles Purchase And Sale for the trailing twelve months (TTM) ended in Sep. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-1.92 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Trinity Biotech Net Intangibles Purchase And Sale Related Terms

Thank you for viewing the detailed overview of Trinity Biotech's Net Intangibles Purchase And Sale provided by GuruFocus.com. Please click on the following links to see related term pages.

Trinity Biotech (Trinity Biotech) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Trinity Biotech PLC (NAS:TRIB) » Definitions » Net Intangibles Purchase And Sale
Comparable Companies
TTOO PMD STRR CHEK SLDX CNTG MYNZ PRPO BIAF XWEL TSE:2309 TMO DHR IQV IDXX XSWX:LONN A MTD ICLR ILMN
Traded in Other Exchanges
TRBA:Germany
Address
IDA Business Park, Bray, County Wicklow, Dublin, IRL, A98 H5C8
Website
https://www.trinitybiotech.com
Trinity Biotech PLC is in the business of development, manufacturing, and marketing clinical diagnostic products for clinical laboratory and point of care sections of the diagnostic market. Its products are used to detect autoimmune, infectious, sexually transmitted diseases, diabetes, and disorders of the liver and intestine. The company also provides raw materials to the life sciences and research industries globally. It markets products under the brand names Recombigen, Unigold, MarBlot, Mardx, Premier, Immublot, EZ, Capita, and others. Geographically, it has two segments namely the Americas, and Rest of World - Ireland of which it derives a majority of its revenues from the Americas segment.